title: Discrepancies in insulin-like growth factor signaling? No, not really.
abstract: Why do studies on insulin-like growth factors (IGFs) and IGF signaling seem so contradictory? The answer is "It depends". This mini- review will explore a few of the factors that are likely to contribute to a seemingly confusing message. Most of the evidence comes from experimental animal models.
authors: Endocrine Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electronic address: Conover.Cheryl@mayo.edu.
authors: Cheryl A
authors: CA
authors: Conover
mesh_terms: D000818:Animals; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D013006:Growth Hormone; D017526:Receptor, IGF Type 1
keywords: IGF; IGF-I receptor; IGFBP